Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-13

FDA Approved: ENTECAVIR — Supplemental Application (Solco Healthcare LLC)

View source ↗

Summary

FDA approved Solco Healthcare LLC's supplemental application for ENTECAVIR (entecavir) under ANDA208782.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)

Snippet

SUPPL AP for ENTECAVIR (ENTECAVIR)